We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
AUM
$3B
AUM Growth
-$844M
Cap. Flow
-$1.01B
Cap. Flow %
-33.73%
Top 10 Hldgs %
26.42%
Holding
246
New
68
Increased
28
Reduced
60
Closed
83

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$76.1M
2
PFE icon
Pfizer
PFE
+$68.2M
3
HON icon
Honeywell
HON
+$47.8M
4
FWONA icon
Liberty Media Series A
FWONA
+$43.6M
5
MEOH icon
Methanex
MEOH
+$41.5M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$154M
2
SIG icon
Signet Jewelers
SIG
+$71.5M
3
IP icon
International Paper
IP
+$64M
4
DIS icon
Walt Disney
DIS
+$62.5M
5
MHK icon
Mohawk Industries
MHK
+$58M

Sector Composition

Rank Sector Weight
1 Financials 13.62%
2 Technology 12.79%
3 Communication Services 12.02%
4 Industrials 11.66%
5 Healthcare 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGU
126
DELISTED
Agrium
AGU
$4.95M 0.16%
+53,985
New +$5.01M
BLOX
127
DELISTED
Infoblox Inc
BLOX
$4.93M 0.16%
+375,000
New +$6.42M
WYNN icon
128
Wynn Resorts
WYNN
$10.1B
$4.77M 0.16%
+23,000
New +$4.77M
MGM icon
129
MGM Resorts International
MGM
$11.7B
$4.75M 0.16%
+180,000
New +$4.5M
WCG
130
DELISTED
Wellcare Health Plans, Inc.
WCG
$4.48M 0.15%
+60,000
New +$4.28M
CIT
131
DELISTED
CIT Group Inc.
CIT
$4.41M 0.15%
+96,392
New +$4.35M
REGN icon
132
Regeneron Pharmaceuticals
REGN
$68.8B
$4.26M 0.14%
+15,081
New +$4.47M
JONE
133
DELISTED
Jones Energy, Inc.
JONE
$4.21M 0.14%
11,170
-10,304
-48% -$3.18M
UFS
134
DELISTED
DOMTAR CORPORATION (New)
UFS
$4.13M 0.14%
96,388
-56,946
-37% -$2.67M
HXL icon
135
Hexcel
HXL
$8.32B
$4.11M 0.14%
+100,570
New +$4.18M
MAS icon
136
Masco
MAS
$16B
$4M 0.13%
+205,027
New +$3.86M
BDC icon
137
Belden
BDC
$4B
$3.91M 0.13%
+50,000
New +$3.67M
MOS icon
138
The Mosaic Company
MOS
$7.09B
$3.71M 0.12%
75,000
-125,000
-63% -$6.16M
GIII icon
139
G-III Apparel Group
GIII
$1.47B
$3.67M 0.12%
+89,914
New +$3.39M
TVTX icon
140
Travere Therapeutics
TVTX
$5.33B
$3.61M 0.12%
307,293
+42,492
+16% +$576K
TUES
141
DELISTED
Tuesday Morning Corp
TUES
$3.56M 0.12%
200,000
-25,000
-11% -$390K
KYTH
142
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$3.35M 0.11%
87,208
+1,216
+1% +$42.4K
BMRN icon
143
BioMarin Pharmaceuticals
BMRN
$11.5B
$3.3M 0.11%
+53,000
New +$3.2M
GPRE icon
144
Green Plains
GPRE
$1.19B
$3.29M 0.11%
100,000
SNY icon
145
Sanofi
SNY
$104B
$3.25M 0.11%
61,027
-182,002
-75% -$9.66M
DD icon
146
DuPont de Nemours
DD
$18.6B
$2.57M 0.09%
19,744
-157,952
-89% -$20.1M
SBNY
147
DELISTED
Signature Bank
SBNY
$2.56M 0.09%
+20,266
New +$2.44M
CASH icon
148
Pathward Financial
CASH
$1.81B
$2.43M 0.08%
182,256
+3,885
+2% +$51.1K
ICUI icon
149
ICU Medical
ICUI
$3.93B
$2.13M 0.07%
35,000
-120,000
-77% -$7.08M
XNPT
150
DELISTED
XENOPORT, INC.
XNPT
$2.06M 0.07%
+426,226
New +$1.81M

Similar funds

Ascend Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Ascend Capital held 246 positions worth $3B, down 22% from $3.85B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ascend Capital withdrew a net $1.01B in Q2 2014, closing 83 positions and reducing 60 holdings. Its most notable exit was Verizon, an estimated $154M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Ascend Capital opened a new position in Pfizer worth $67.4M.

  • Ascend Capital's largest Q2 2014 buy was Pfizer: 2,391,995 shares worth $67.4M.
  • Ascend Capital added most to RTX Corp in Q2 2014, an estimated $76.1M increase.
  • Ascend Capital's biggest Q2 2014 reduction was International Paper, cutting an estimated $64M.
  • Ascend Capital fully exited Verizon in Q2 2014, selling an estimated $154M.
  • Ascend Capital's ten largest holdings make up 26% of its $3B portfolio in Q2 2014.
  • Ascend Capital opened 68 new positions and closed 83 in Q2 2014.
  • Ascend Capital's portfolio value fell 22% quarter-over-quarter to $3B.

Based on Ascend Capital's 13F filing for Q2 2014, filed 13 Aug 2014.